🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Mometasone + Azelastine

Found 9 matching trials

4"S" - Seasonal Symptoms Suppression Study

PHASE4

ASIT naïve patients sensitized to grass pollens will be recruited for the s...

Status

Unknown

Location

Medical University Sofia, University Hospital "Alexandrovska", Clinic of Allergy and Asthma

Start Date

2015-05

Trial ID

NCT02557269

Treatments Being Tested

Xylometazoline - intranasal application Azelastine - intranasal application Mometasone furoate - intranasal application Hydroxyl-propyl-methyl cellulose powder - intranasal application Placebo - Lactose powder Bilastine 20 mg Prednisolone 5 mg

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)

PHASE2

A single-center, double-blind, placebo-controlled study of FDC olopatadine ...

Status

Completed

Location

Glenmark Investigational Site 1

Start Date

2014-01-27

Trial ID

NCT03444506

Treatments Being Tested

Molo 1 (also referred as GSP 301-2 NS)Molo 2 (also referred as GSP 301-1 NS)Placebo nasal spray DYMISTA nasal spray PATANASE nasal spray

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

PHASE3

The trial will be conducted as a prospective, randomized, multinational, mu...

Status

Completed

Location

Sandoz Investigative Site

Start Date

2022-04-04

Trial ID

NCT05311475

Treatments Being Tested

Mometasone Azelastine Placebo

Azelastine Allergen Chamber - Onset of Action Study

PHASE2

This study is to assess the Onset of Action and Efficacy of azelastine hydr...

Status

Completed

Location

Cliantha Research

Start Date

2023-10-30

Trial ID

NCT06126952

Treatments Being Tested

Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)Treatment B: Placebo (Azelastine 0.15% vehicle) nasal spray Treatment C: Ryaltris (Active Control) - mometasone furoate monohydrate and olopatadine hydrochloride nasal spray

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

PHASE3

The purpose of this study is to determine if one allergy treatment (0.15% a...

Status

Completed

Location

Center of Research Excellence, LLC

Start Date

2007-03

Trial ID

NCT00720382

Treatments Being Tested

0.15% azelastine hydrochloride Mometasone furoate

Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis

PHASE3

The purpose of this study is to evaluate of efficacy and safety of mometaso...

Status

Completed

Location

Seoul National University Hospital

Start Date

2011-03

Trial ID

NCT01470053

Treatments Being Tested

mometasone furoate plus azelastine HCl mometasone furoate azelastine HCl

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

PHASE1

This study will compare the PK parameters of the combination test formulati...

Status

Terminated

Location

Sandoz Investigational Site

Start Date

2023-06-08

Trial ID

NCT05887843

Treatments Being Tested

Mometasone + Azelastine Mometasone Furoate Azelastine Hydrochloride

Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis

PHASE4

The goal of this clinical trial is to determine the best combination of dru...

Status

Recruiting

Location

Northshore University HealthSystem

Start Date

2022-11-23

Trial ID

NCT05626621

Treatments Being Tested

Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray Mometasone Nasal Irrigation (1 mg capsule)Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

PHASE3

Prospective, multicenter, open, randomized, parallel, clinical study for as...

Status

Completed

Location

Sandoz Investigative Site

Start Date

2023-02-13

Trial ID

NCT05590598

Treatments Being Tested

Azelastine + Mometazone, nasal spray Momat Rhino Advance

Previous Next